Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Scientific Officer
-
Stock Symbol
-
TRVI on Nasdaq
Thomas Sciascia - trading volume in the past year for Trevi Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
221K |
$1.46M |
$6.60 |
Mar 25, 2025 |
Direct |
|
|
| Performance Stock Option (right to buy) |
92K |
|
|
May 31, 2025 |
Direct |
Common Stock |
|
| Stock Option (right to buy) |
0 |
|
|
Mar 25, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.